BG105996A - Method of treating eating disorders - Google Patents

Method of treating eating disorders

Info

Publication number
BG105996A
BG105996A BG105996A BG10599601A BG105996A BG 105996 A BG105996 A BG 105996A BG 105996 A BG105996 A BG 105996A BG 10599601 A BG10599601 A BG 10599601A BG 105996 A BG105996 A BG 105996A
Authority
BG
Bulgaria
Prior art keywords
eating disorders
treating eating
treating
nervosa
snacking
Prior art date
Application number
BG105996A
Other languages
Bulgarian (bg)
Other versions
BG65170B1 (en
Inventor
Carl Mendel
Timothy SEATON
Steve Weinstein
Original Assignee
Abbott Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Gmbh & Co. Kg filed Critical Abbott Gmbh & Co. Kg
Publication of BG105996A publication Critical patent/BG105996A/en
Publication of BG65170B1 publication Critical patent/BG65170B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone

Landscapes

  • Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

A compound of formula or a pharmaceutically acceptable salt thereof in which R1 and R2 are independently H or methyl (for example N,N-dimethyl-1-[1-(4-chlorphenyl)cyclobutyl]-3-methylbutyl amine hydrochloride optionally in the form of monohydrate) is used for treating eating disorders, such as anorexia nervosa, bulimia nervosa, weight-gain after smoking cessation, snacking or binge eating. 15 claims
BG105996A 1999-03-17 2001-10-10 Use of n-substituted derivatives of 1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl amine for the production of a medicine for treating eating disorders BG65170B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12515099A 1999-03-17 1999-03-17

Publications (2)

Publication Number Publication Date
BG105996A true BG105996A (en) 2002-06-28
BG65170B1 BG65170B1 (en) 2007-05-31

Family

ID=38229636

Family Applications (1)

Application Number Title Priority Date Filing Date
BG105996A BG65170B1 (en) 1999-03-17 2001-10-10 Use of n-substituted derivatives of 1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl amine for the production of a medicine for treating eating disorders

Country Status (1)

Country Link
BG (1) BG65170B1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE52768B1 (en) * 1981-04-06 1988-02-17 Boots Co Ltd 1-arylcyclobutylalkylamine compounds useful as therapeutic agents
GB8531071D0 (en) * 1985-12-17 1986-01-29 Boots Co Plc Therapeutic compound
GB8704777D0 (en) * 1987-02-28 1987-04-01 Boots Co Plc Medical treatment
JP2675573B2 (en) * 1988-03-31 1997-11-12 科研製薬株式会社 Brain function improver
IE61928B1 (en) * 1988-11-29 1994-11-30 Boots Co Plc Treatment of obesity
US5459164A (en) * 1994-02-03 1995-10-17 Boots Pharmaceuticals, Inc. Medical treatment

Also Published As

Publication number Publication date
BG65170B1 (en) 2007-05-31

Similar Documents

Publication Publication Date Title
MXPA01009404A (en) Method of treating eating disorders.
GEP20084391B (en) Pyrazoles and methods of making and using the same
CZ305838B6 (en) N-(2-arylethyl)benzylamines as 5-HT6 receptor antagonists
WO2001032652A3 (en) N-substituted carbamoyloxyalkyl-azolium derivatives
MX9605128A (en) Neurokinine (tachykinine) antagonists.
WO2002057252A3 (en) Heterocyclic sulfonamide inhibitors of beta amyloid production
SI0773943T1 (en) Compounds useful as antiproliferative agents and garft inhibitors
AU2003239389A1 (en) Opioid receptor antagonists
GEP20074045B (en) (4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease
MXPA04002495A (en) Imidazopyridine compounds as 5-ht4.
MY138826A (en) 2,7-substituted indoles
WO2000056315A8 (en) Treatment of pain
IL145645A0 (en) N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists
BG106001A (en) Method of treating sleep apnoea
BG105996A (en) Method of treating eating disorders
NZ504124A (en) Phenyl-alkyl-imidazoles and use in treating inflammatory disease
BG105999A (en) Treatment of osteoarthritis
MXPA04004075A (en) Compounds and method for the treatment of overactive bladder.
NO20063299L (en) Synthesis of a polymorph of 4-amino-5-chloro-2-methoxy-N- (1-azabicyclo [3.3.1] non-4-yl) benzamide hydrochloride hydrate
MXPA01009469A (en) Treatment to lower platelet adhesiveness.
MXPA03007309A (en) Thiophene substituted amine derivatives as glyt-1 inhibitors.
MXPA01009468A (en) Treatment of pulmonary hypertension.
BG106000A (en) Treatment of hiatial hernia
HU9401765D0 (en) Loracarbef hydrochloride c1-c3 alcohol solvates and uses thereof
EP1234576A4 (en) Us0027324for eating disorders